Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.97 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.97 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.97 |
| ▸ | DRD3 | P35462 | 2/20 | 0.97 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.97 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.97 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.97 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.97 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.97 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.97 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.69 |
| ▸ | LMNA | P02545 | 4/20 | 0.69 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.51 |
| ▸ | MITF | O75030 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | GFER | P55789 | 1/20 | 0.48 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Eperisone SCHEMBL194769 | 0.98 | HRH3 (1.00) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Eperisone SCHEMBL1331682 | 0.98 | HRH3 (1.00) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Inaperisone SCHEMBL3990438 | 0.98 | CHRM2 (0.94) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Inaperisone SCHEMBL1650087 | 0.97 | HRH3 (0.92) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Eperisone SCHEMBL218337 | 0.97 | HRH3 (0.97) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Hydrochloric Acid SCHEMBL9850399 | 0.92 | CHRM2 (0.83) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Eperisone SCHEMBL2491287 | 0.92 | HRH3 (0.87) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Eperisone SCHEMBL1329969 | 0.92 | HRH3 (0.87) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Eperisone SCHEMBL1331476 | 0.91 | HRH3 (0.85) | HRH3CHRM2ADRA2BDRD3SIGMAR1 | |
| Eperisone SCHEMBL2489151 | 0.91 | HRH3 (0.85) | HRH3CHRM2ADRA2BDRD3SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2338 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12529035-B1 | Method for producing induced pluripotent stem cells | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2026-01-20 | — | — | US | claimed |
| US-20260000734-A1 | METHODS FOR EXPANDING AND ACTIVATING yo T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES | IMMATICS US INC (US) | 2026-01-01 | — | — | US | claimed |
| WO-2025261951-A1 | COMBINATION THERAPY WITH AN ANTI-CA19-9 ANTIBODY AND FOLFIRINOX IN THE TREATMENT OF CANCER | BioNTech SE (DE) | 2025-12-26 | — | — | WO | claimed |
| EP-3717634-B1 | METHODS FOR ACTIVATING, MODIFYING AND EXPANDING GAMMA DELTA T CELLS FOR THE TREATMENT OF CANCER AND RELATED MALIGNANCIES | IMMATICS US INC (US) | 2025-10-15 | — | — | EP | claimed |
| US-12440541-B2 | Methods for expanding and activating γσ T cells for the treatment of cancer and related malignancies | Immatics US, Inc. (US) | 2025-10-14 | — | — | US | claimed |
| EP-4602049-A1 | SOS1 INHIBITORS | Bayer Aktiengesellschaft (DE) | 2025-08-20 | — | — | EP | claimed |
| EP-4587439-A1 | SULFONE-SUBSTITUTED PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF CANCER | Bayer Aktiengesellschaft (DE) | 2025-07-23 | — | — | EP | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20250154170-A1 | FUSED PYRIMIDINES AS KRAS INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2025-05-15 | — | — | US | claimed |
| WO-2025021997-A1 | NEW MAP4K1 INHIBITORS | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2025-01-30 | — | — | WO | claimed |
| CN-1116900-C | Solvent and external preparation containing the same | HISAMITSU PHARMACEUTICAL CO (JP) | 2003-08-06 | — | — | CN | claimed |
| EP-1232751-A1 | REMEDIES FOR PERIODONTOSIS | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 2002-08-21 | — | — | EP | claimed |
| EP-0850086-A1 | DEVICE FOR THE IONTOPHORETIC ADMINISTRATION OF BISPHOSPHONATES | Becton, Dickinson and Company (US) | 1998-07-01 | — | — | EP | claimed |
| US-5770221-A | HIGH AND LOW MOLECULAR WEIGHT POLYISOBUTYLENE | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 1998-06-23 | — | — | US | claimed |
| US-5735810-A | A MEDICAL EQUIPMENT FOR TRANSDERMAL DRUG DELIVERING A THERAPEUTIC DRUG TREATING BONE DISORDER OSTEOPOROSIS | BECTON DICKINSON AND COMPANY (US) | 1998-04-07 | — | — | US | claimed |
| US-5730715-A | BONE DISORDERS | BECTON DICKINSON AND COMPANY (US) | 1998-03-24 | — | — | US | claimed |
| WO-1997047356-A1 | DEVICE FOR THE IONTOPHORETIC ADMINISTRATION OF BISPHOSPHONATES | BECTON, DICKINSON AND COMPANY (US) | 1997-12-18 | — | — | WO | claimed |
| EP-0273375-B2 | Propiophenone derivatives for treatment of pollakiuria (frequency urination) | HOKURIKU PHARMACEUTICAL (JP) | 1995-05-10 | — | — | EP | claimed |
| US-4912116-A | Propiophenone derivatives for treatment of pollakiuria (frequency urination) | HOKURIKU PHARMACEUTICAL CO., LTD. (JP) | 1990-03-27 | — | — | US | claimed |
| US-4638009-A | MUSCLE RELAXANTS | HOKURIKU PHARMACEUTICAL CO., LTD. (JP) | 1987-01-20 | — | — | US | claimed |